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Abstract
Background Although studies comparing the surgical
treatment of gastric carcinoma in Japan and Western
industrialized countries have revealed differing survival
rates, no studies to date have been performed comparing
Western and Eastern Europe. This study aimed to compare
demographics and surgical practice as well as the related
prognostic impact on gastric cancer patients treated in
Poland and Germany.
Methods This retrospective study included gastric cancer
patients treated between 1999 and 2004 by surgical
departments in Gdansk (Poland) and Cologne (Germany).
Univariate and multivariate analyses of demographic,
histopathological, surgical, and prognostic data were
performed.
Results Included were 117 patients from Gdansk and 130
patients from Cologne. The Cologne patients showed
higher incidence rates of serious comorbidity, pT1 cancer,
and distant metastasis than those from Gdansk. Indications
for and frequency of selected surgical procedures differed
signiﬁcantly. D2-lymphadenectomy was performed in 89%
of the Cologne patients, while D1-lymphadenectomy was
done for 85% of the Gdansk patients. Univariate analysis
yielded a 5-year survival rate of 28.3% for the Gdansk
patients, and 40.3% for the Cologne patients (p = 0.056).
Independent prognostic factors were pT category (p =
0.002), pN category (p\0.001), pM category (p = 0.027),
residual tumor (R) category (p = 0.004), age (p = 0.012),
and number of resected lymph nodes (p = 0.005).
Conclusions Signiﬁcant differences of clinical and sur-
gical parameters exist between gastric cancer patients
treated in Poland and Germany. In addition to established
independent prognostic factors, we found that survival
improved with each additionally resected lymph node.
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Introduction
Gastric cancer is one of the most common malignancies
worldwide [1]. Despite decreasing incidence rates in Wes-
tern industrialized countries, gastric carcinoma remains in
the top ten causes of tumor-related death in Germany [2].
The incidence rate of stomach cancer in Poland, also
decreasing, is similar to that of Germany, with 16.9 cases
per 100,000 population (1993–1997) [3]. Although surgery
remains the only curative treatment, the type of operative
treatment used for gastric cancer varies geographically [4].
Increased survival may depend on early detection made
possible with endoscopy, surgical resection including
appropriate lymph node dissection, and improvements in
perioperative care. Differing survival rates have been
reported for patients receiving surgical intervention in
Japan versus those in Western industrialized countries
[5, 6]. However, for patients with gastric cancer, there exists
no published prognostic comparison between Eastern and
Western Europe.
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DOI 10.1007/s10120-011-0036-2The purpose of this study was to compare the charac-
teristics of gastric cancer patients and the prognostic
impact between two surgical departments: one in Gdansk
(Poland), and the other in Cologne (Germany).
Patients and methods
Patients
The period of the study was 1 January 1999 until 31
December 2004. Patients underwent surgery with curative
intent for primary gastric cancer. There were 117 patients
(90% of all patients with gastric cancer) in Gdansk
(Department of Surgical Oncology, Medical University of
Gdansk [Poland]), and 130 patients (85% of allpatientswith
gastric cancer) inCologne (Department ofGeneral, Visceral
and Cancer Surgery, University of Cologne [Germany]).
Inclusion criteria were: histopathologically conﬁrmed gas-
tric cancer (from gastroscopy), no signs of metastases in
preoperative assessment, andoperabletumor. Inallpatients,
the preoperative assessment of gastric cancer included not
only gastroscopy but also standard laboratory tests, chest
X-ray. and thoracic and abdominal computed tomography
(CT) scans. Besides, in case of doubt the patients underwent
laparoscopy (in Cologne), and a few patients had peritoneal
cytology assessment performed. The comorbidity of a
patient was classiﬁed according the American Society of
Anesthesiologists’ Physical Status: ASA classiﬁcation
[7, 8]. For both centers the ASA grade assessment was
reevaluated by one doctor according tothe patient’s medical
history. Cardiac evaluation was mostly based on reviewing
the patient’s medical history and assessing the coexistence
of coronary disease, arterial hypertension, diabetes mellitus,
and the New York Heart Association (NYHA) score. All
patients had electrocardiograms performed. Respiratory
system evaluation included analysis of the patient’s medical
history,medicalexaminationofthepatient,andchestX-ray.
Patientswho hada prior historyofa respiratory disorder had
spirometry performed and its result had an impact on the
ﬁnal ASA score.
Surgical procedures
InCologne,theguidelinesoftheGermanSocietyofSurgery
were used to evaluate indications for therapy and the
selection of the surgical procedure [9, 10]. Summarized,
these guidelines are as follows: endoscopic mucosal resec-
tion and submucosal dissection are indicated in superﬁcial
cancer conﬁned to the mucosa with special characteristics
(T1a/no ulcer/G1,2/Laure ´n intestinal/L0/V0/tumor size\2
cm). In all other cases total gastrectomy or distal subtotal
gastric resection are indicated, the latter in cases of tumors
located in the distal two-thirds of the stomach. Standard
lymphadenectomy (LAD) is the D2-LAD without distal
pancreatectomy or splenectomy. Carcinoma in the cardia or
upper third of the stomach, classiﬁed according to Siewert
et al. [11] as type II or III tumors, can be treated by an
extended total gastrectomy with a transhiatal resection of
the distal esophagus and LAD of the lower mediastinum and
the abdominal D2 compartment. Extended organ resections
are onlyindicated in cases whereR0 resection is possible. In
Gdansk, the main goal of surgical intervention was the
complete removal of tumor. Indications for performing
either subtotal gastrectomy, total gastrectomy, or extended
total gastrectomy werebased ontumorlocation,histological
type, and trial for achieving surgical tumor-free margins.
Splenectomy was carried out after iatrogenic stimulus or
when there was apparent direct inﬁltration of tumor.
Reconstruction of the digestive tract was performed with
either BillrothII reconstruction (after subtotalgastrectomy),
or with the Roux-en-Y reconstruction technique.
Histopathology
Resected specimens were routinely ﬁxed in 5% phosphate-
buffered formalin and embedded in parafﬁn. Histopathol-
ogical examination of all resected specimens consisted
of a thorough and standardized evaluation of tumor stage,
residual tumor (R) category, grading, and number of
resected and inﬁltrated lymph nodes. Postoperative staging
was done according to the 6th edition of the International
Union Against Cancer (UICC)-TNM classiﬁcation of
malignant tumors [12]. Gastric lymph nodes were docu-
mented according to the classiﬁcation of the Japanese
Research Society of Gastric Cancer (JRSGC), with lymph
node groups 1–13. Tumor localization was deﬁned
according to the International Classiﬁcation of Diseases for
Oncology. Lesions were further classiﬁed and graded in
accordance with the WHO recommendations, the Laure ´n
classiﬁcation, and tumor differentiation (G1–G4) [13].
Statistical analysis
Data were collected and analyzed retrospectively.
Descriptive analysis included the frequency of nominal
parameters, the median with the lower quartile (LQ) and
upper quartile (UQ) for numeric variables (ordinal or
asymmetric distribution), and the mean for numeric vari-
ables with normal distribution. Univariate analysis was
calculated for tables using v
2statistics with the Yates cor-
rection or Fisher’s exact test if necessary. The Mann–
Whitney U-test was used to compare continuous variables.
More than 90% of the patients had a follow-up duration
longer than four years. There was no difference of follow-up
between the two centers. Univariate survival analysis was
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123conducted according to Kaplan–Meier, and survival curves
were compared with the log rank test [14]. In addition, the
hazard ratio with the 95% conﬁdence interval (95% CI) was
calculated. Multivariate analysis was performed by the Cox
regression method, using the backward option, meaning:
ﬁrst enter all variables into the model and then remove
nonsigniﬁcant variables sequentially. Assuming that the
hazard function for Gdansk was different from that for
Cologne over time, we stratiﬁed according to center [15].
Statistical signiﬁcance was set at p\0.05. For statisti-
cal analysis, the SPSS for Windows (version 17.0) appli-
cation (SPSS, Chicago IL, USA) was used. For graphical
presentation of the survival curve, the statistical program
MedCalc for Windows Version 11.4 (MedCalc Software,
Mariakerke, Belgium) was used.
Results
Demographics
There were 117 gastric cancer patients from Gdansk and
130 from Cologne. The proportion of females was signiﬁ-
cantly (p = 0.019) higher in the Polish group (41.9%)
compared to the German group (27.7%). Patients from
Gdansk were younger, with a median age of 63.9 years
compared to those from Germany (median 66.8 years);
however, the difference was not statistically signiﬁcant
(p = 0.212). Cologne patients had signiﬁcantly (p\0.001)
more severe comorbidities (ASA III and IV) than patients in
Gdansk. The demographic characteristics are shown in
Table 1.
Table 1 Demographic and
histopathological data from
patients treated surgically for
gastric carcinoma from Gdansk
(Poland) and Cologne
(Germany)
ASA anesthesia risk according to
American Society of
Anesthesiologists [7, 8], pT
tumor inﬁltration depth into
gastric wall, pN lymph node
status, pM0 no distant
metastases, pM1 distant
metastases
Feature Gdansk, Poland
(n = 117)
Cologne, Germany
(n = 130)
p value
Demographics
Gender
Males 68 (58.1%) 94 (72.3%) 0.019
Females 49 (41.9%) 36 (27.7%)
Median age (min–max)
All patients 63.9 years (26–88 years) 66.8 years (31–87 years) 0.212
Males 63.3 years 66.7 years 0.063
Females 67.8 years 67.0 years 0.972
Comorbidities
ASA I and II 77 (65.5%) 51 (39.0%) \0.001
ASA III and IV 40 (34.5%) 79 (61.0%)
Histopathology
Tumor localization
Upper third 43 (36.8%) 59 (45.4%) 0.356
Middle third 41 (35.0%) 37 (28.5%)
Lower third 33 (28.2%) 34 (26.2%)
Type of histopathology (WHO)
Adenocarcinoma 100 (85.3%) 82 (63.2%) \0.001
Signet-ring cell carcinoma 16 (13.7%) 45 (34.4%)
Other histology 1 (1.0%) 3 (2.4%)
pT category
pT1 6 (4.8%) 29 (22.3%) \0.001
pT2 22 (19.0%) 28 (21.5%)
pT3 72 (61.9%) 37 (28.5%)
pT4 17 (14.3%) 36 (27.7%)
pN category
pN0 37 (31.3%) 44 (33.8%) 0.339
pN1 42 (35.7%) 41 (31.5%)
pN2 29 (25.0%) 26 (20.0%)
pN3 9 (8.0%) 19 (14.6%)
pM category
pM0 100 (85.6%) 93 (71.5%) 0.009
pM1 17 (14.4%) 37 (28.5%)
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123Histopathology
The tumor was located in the upper third of the stomach for
nearly half of the patients in both clinics. There was no
signiﬁcant difference in tumor localization. Signet-ring
cell carcinoma histology was diagnosed signiﬁcantly
(p\0.001) more often in patients from Cologne (34.4%)
versus those from Gdansk (13.7%). In contrast, the Polish
patients showed signiﬁcantly (p\0.001) more advanced
pT categories than the German patients. At a rate of only
5%, early cancer was a rare diagnosis in Gdansk, in con-
trast to the Cologne group, where the frequency was 22%
(p\0.001). More details are provided in Table 1.
Surgical treatment
The details of surgical practice are listed in Table 2. Pro-
cedure frequency and indications for the various interven-
tions differed between the two clinics. The 30- and 90-day
mortality rates did not differ between the clinics, at 0.9 and
5.9% in Gdansk versus 2.3 and 4.6% in Cologne.
Prognosis
Univariate analysis identiﬁed no signiﬁcant difference in
prognosis between the two surgical departments (Table 3).
The estimated 5-year overall survival rate for patients from
Gdansk was 28.3% and that for patients from Cologne was
40.3% (p = 0.056), with a hazard ratio of 0.71 (95% CI
0.54–1.01) (Fig. 1). In the univariate analysis performed
separately for each center, the following prognostic factors
were identiﬁed as signiﬁcant for both centers: clear surgical
resection margin (R0 category), pT, pN, and pM category
(p\0.001 for each). In Cologne, there was improved
survival in younger (\60 years) versus older patients
(C60 years) (p = 0.021). For patients from Gdansk, tumor
localization (p = 0.012), histological tumor type (p =
0.001), and type of lymphadenectomy performed (p =
0.031) had prognostic relevance. The following parameters
did not inﬂuence survival in either clinic: gender, comor-
bidity (ASA I and II vs. III and IV), type of gastric
resection, and splenectomy.
On comparison of the clinics, parameters responsible for
the better prognosis in Cologne were healthy baseline
status (ASA I or II), signet-ring cell carcinoma histology,
and absence of distant metastasis (Table 3).
The most relevant prognostic factors from the univar-
iate survival analysis were used for multivariate analysis:
pT, pN, pM, and R category. In addition, the parameters
age (continuous variable), gender, comorbidity, tumor
localization, histology, and the number of resected lymph
nodes (continuous variable) were included. Cox regres-
sion analysis was stratiﬁed according to surgical depart-
ment. Table 4 shows the independent prognostic factors.
The established independent prognostic factors, pT, pN,
pM, and R category, were conﬁrmed with our analysis.
Patient age was an independent prognostic factor, with a
hazard ratio of 1.022 for each subsequent year. As well,
each additional resected lymph node improved the
prognosis.
Table 2 Surgical treatment of
patients with gastric cancer
from Gdansk (Poland) and
Cologne (Germany)
R0 no residual tumor resection,
R1 microscopic residual tumor
resection, R2 macroscopic
residual tumor resection, D1
limited lymph node dissection
group, D2 extended lymph node
dissection group
Feature Gdansk, Poland
(n = 117)
Cologne, Germany
(n = 130)
p value
Type of resection
Subtotal gastrectomy 14 (11.8%) 17 (13.4%) \0.001
Total gastrectomy 82 (70.0%) 40 (30.7%)
Extended gastrectomy 20 (17.3%) 36 (27.6%)
Transhiatal extended gastrectomy 0 (0%) 36 (27.6%)
Others 1 (0.9%) 1 (0.8%)
Splenectomy
Splenectomy during gastrectomy 67 (57.1%) 26 (19.8%) \0.001
R0 resection
R0 103 (87.7%) 119 (91.5%) 0.389
R1/R2 14 (12.3%) 11 (8.5%)
Lymphadenectomy
D1 99 (84.8%) 14 (10.6%) \0.001
D2 18 (15.2%) 116 (89.4%)
Number of resected lymph nodes
Median (min–max) 13.0 (0–47) 33.5 (3–82) \0.001
Number of metastatic lymph nodes
Median (min–max) 3.0 (0–41) 3.0 (0–43) 0.948
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The patient populations from the two clinics studied here
were clearly quite different. Not only did demographic and
tumor characteristics vary, but also the indications for
choice of therapy and the radicality of surgical intervention
performed varied. Despite these differences, established
independent prognostic factors for gastric carcinoma, such
as depth of tumor inﬁltration, extent of lymph node
metastasis, and presence of distant metastasis, as well as R0
resection, were reconﬁrmed by our results. The importance
of these prognostic factors for the comparison between
Table 3 Univariate survival analysis comparing the impact of demographic and histopathological factors between 117 patients with gastric
cancer from Gdansk (Poland) and 130 patients from Cologne (Germany)
Univariate survival analysis:
5 year survival rate
Gdansk, Poland
(n = 117) (%)
p value Cologne, Germany
(n = 130) (%)
p value p value between
the two centers
Gender
Male 30.1 0.388 42.3 0.962 0.168
Female 20.4 35.2 0.336
Comorbidities
ASA I and II 26.5 0.691 47.3 0.102 0.017
ASA III and IV 30.7 36.1 0.781
Tumor localization
Upper third 32.9 0.012 42.1 0.524 0.325
Middle third 14.6 32.1 0.202
Lower third 40.1 47.1 0.529
Histopathological classiﬁcation (WHO)
Adenocarcinoma (except for signet-ring cell cancer) 32.2 0.001 39.9 0.524 0.237
Signet-ring cell cancer 0.0 39.9 0.007
pT category
pT1 – \0.001 64.4 \0.001 –
pT2 45.2 46.7 0.928
pT3 18.7 35.8 0.271
pT4 0.0 18.7 0.201
pN category
pN0 59.5 \0.001 63.1 \0.001 0.592
pN1 20.4 44.4 0.079
pN2 0.0 13.4 0.079
pN3 0.0 13.0 0.916
pM category
pM0 32.0 \0.001 53.9 \0.001 0.013
pM1 0.0 8.5 0.175
R category
R0 31.6 \0.001 41.8 \0.001 0.179
R1/R2 0 0 0.107
Type of gastric resection
Subtotal resection 44.0 0.116 50.4 0.829 0.752
Total gastrectomy 29.9 34.1 0.437
Extended gastrectomy 15.8 24.0 0.314
Transhiatal extended gastrectomy – 52.2 –
Lymphadenectomy
D1 25.1 0.031 19.2 0.165 0.804
D2 47.1 42.8 0.521
ASA anesthesia risk according to American Society of Anesthesiologists [7, 8], pT tumor inﬁltration depth into gastric wall, pN lymph node
status, pM0 no distant metastases, pM1 distant metastases, R category: R0 no residual tumor resection, R1 microscopic residual tumor resection,
R2 macroscopic residual tumor resection, D1 limited lymph node dissection group, D2 extended lymph node dissection group
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123nations has already been reported in studies comparing
Japan and Western industrialized nations [5, 6]. Depth of
tumor inﬁltration and the extent of metastasis, as well as the
possibility for an R0 resection selected from suitable sur-
gical procedures, are clinical features that patients possess
before entering a clinic. This applies also for the age of the
patient. In contrast are the frequency of successful R0
resections and the extent of lymphadenectomies performed,
which are determined at least partially by the operating
surgeon.
In terms of patient-related factors, there were more
women in Gdansk than in Cologne who were subjected to
surgery for gastric carcinoma. It is possible that this rep-
resents a selection bias, because the incidence of gastric
carcinoma in women in the two countries does not differ.
Age and comorbidity also affect prognosis [16]. Although
the age distribution at the two clinics did not differ, pre-
sentation of the illness later in life does decrease life
expectancy. Age also correlates with the severity of
comorbidities, a fact that could explain why more severe
comorbidity appears to have no prognostic relevance [17].
Furthermore, the parameter chosen here, the ASA classiﬁ-
cation, is a nonspeciﬁc measure to estimate prognosis [18].
The main difference in clinicopathological features was
seen in the depth of tumor invasion into the gastric wall.
Early gastric cancer was more prevalent in Cologne than in
Gdansk. This correlates with data published by the Polish
Gastric Cancer Study Group and the ‘‘German Gastric
Cancer Study, for Gdansk and Cologne, respectively [19–
21]. We believe that the observed differences in tumor
stage frequency are secondary to varying schools of
thought in German society and Polish society, as well as
differences in national health policies. There is probably
less access to gastroscopy in Poland than in Germany, and
perhaps Polish patients do not immediately visit general
practitioners with the ﬁrst symptoms of gastric disease.
Although there were differences between the clinics in the
tumor stage assessed at time of operation, the tumor stage
distribution among our patients was nothing like that
observed in Japan, where 56–65% of all gastric cancers are
stage I [22]. This suggests that all European Union coun-
tries must take more care to achieve earlier diagnosis.
Surgeon-dependent factors include the selection of sur-
gical therapy and the radicality of the tumor resection
performed. In Germany, clear guidelines for the therapeutic
approach to gastric cancer exist [10]. As a consequence,
different indications were used by the two clinics to
determine the types of resection and lymphadenectomy
performed and the need for splenectomy, as well as the
number of resected lymph nodes.
One of the most important prognostic factors was the
number of resected lymph nodes. Each additional resected
lymph node improved the probability of survival. These
results correspond to other reports in the literature [22].
Peyre et al. [23] found similar results for patients with
adenocarcinoma of the esophagus or gastric cardia in an
international study assessing the impact of the extent of
surgical resection.
Controversy regarding the optimal extent of lymph node
dissection continues worldwide [24]. An extended lymph
Fig. 1 Comparison of survival curves of gastric cancer patients from
Gdansk (Poland) and from Cologne (Germany) [p = 0.056; hazard
ratio 0.71 (95% conﬁdence interval [CI] 0.54–1.01)]
Table 4 Multivariate survival analysis of independent prognostic
factors for patients with surgically treated gastric carcinoma
Feature Hazard ratio 95% CI p value
Age
Each year 1.022 1.005 0.012
pT category 0.002
pT1–pT2 1.45 0.64–3.30 0.379
pT1–pT3 2.83 1.34–5.93 0.006
pT1–pT4 3.19 1.43–7.13 0.005
pN category \0.001
pN0–pN1 2.36 1.37–4.08 0.002
pN0–pN2 3.08 1.73–5.49 \0.001
pN0–pN3 8.82 4.10–18.98 \0.001
Number of resected LNs
Each LN 0.979 0.97–0.99 0.005
pM category
pM0–pM1 1.81 1.07–3.06 0.027
R category
R0–R1/R2 2.42 1.32–4.45 0.004
CI conﬁdence interval, pT tumor inﬁltration depth into gastric wall,
pN lymph node status, pM0 no distant metastases, pM1 distant
metastases, LN lymph node, R category: R0 no residual tumor
resection, R1 microscopic residual tumor resection, R2 macroscopic
residual tumor resection (according to the 6th edition of the Inter-
national Union Against Cancer (UICC)-TNM classiﬁcation of
malignant tumors [12])
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123node dissection is thought to provide more appropriate
pathological staging and better regional disease control, as
well as possible survival advantages compared to limited
lymph node dissection [25]. Two recent prospective, ran-
domized European trials (in The Netherlands and the
United Kingdom) were designed to evaluate whether
extended lymphadenectomy improves overall survival.
Neither study identiﬁed a difference in survival rates.
However, the results of both studies were inﬂuenced by
increased postoperative morbidity/mortality rates associ-
ated with increased rates of splenectomy and pancreatec-
tomy in patients undergoing D2-dissection [26–29]. In a
review study, McCulloch et al. concluded that the question
of extended versus limited lymph node dissection has not
yet been decided [30].
The fact that 57% of Gdansk patients had splenectomy
performed during gastrectomy came out as an unantici-
pated observation. It was related to the conviction that
removal of the lymph nodes located in the splenic hilum
may be a prognostic marker. Several studies have con-
cluded that the disadvantages of splenectomy outweigh the
prognostic beneﬁts for patients with gastric cancer [22, 31,
32]. The results of our analysis convinced the Gdansk
surgical team to change the strategy of management and to
improve the surgical quality [33]. Currently, the rate of
splenectomies in Gdansk does not exceed 20%.
Conclusions
Despite differences in the frequencies of various prognostic
factors between Polish and German gastric carcinoma
patients, established prognostic factors such as the depth of
tumor inﬁltration, the existence of lymph node or distant
metastasis, and complete removal of the tumor were veri-
ﬁed by our results. Of interest is the simultaneous emer-
gence, at the two study centers, of the number of removed
lymph nodes as an independent prognostic factor.
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